Page last updated: 2024-08-21

androstenediol and androsterone glucuronide

androstenediol has been researched along with androsterone glucuronide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bélanger, A; Brochu, M; Cusan, L; Dupont, A; Labrie, F	1
Baulieu, EE; Brailly, S; Chanson, P; Couzinet, B; Nahoul, K; Schaison, G; Young, J	1
Balser, J; Labrie, F; Martel, C	1

Trials

1 trial(s) available for androstenediol and androsterone glucuronide

Article	Year
Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:8 Topics: Adult; Aged; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Hypopituitarism; Male; Middle Aged; Models, Biological; Placebos; Testosterone	1997

Article

Year

Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.

The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:8

Topics: Adult; Aged; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Hypopituitarism; Male; Middle Aged; Models, Biological; Placebos; Testosterone

1997

Other Studies

2 other study(ies) available for androstenediol and androsterone glucuronide

Article	Year
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma. Clinical and investigative medicine. Medecine clinique et experimentale, 1988, Volume: 11, Issue:5 Topics: Adenocarcinoma; Adrenal Cortex Hormones; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dehydroepiandrosterone; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Kinetics; Luteinizing Hormone; Male; Pregnenolone; Progesterone; Prolactin; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate	1988
Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary? Menopause (New York, N.Y.), 2011, Volume: 18, Issue:1 Topics: Adult; Aged; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Estrone; Female; Humans; Middle Aged; Ovariectomy; Ovary; Postmenopause; Statistics, Nonparametric; Testosterone	2011

Article

Year

Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.

Clinical and investigative medicine. Medecine clinique et experimentale, 1988, Volume: 11, Issue:5

Topics: Adenocarcinoma; Adrenal Cortex Hormones; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dehydroepiandrosterone; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Kinetics; Luteinizing Hormone; Male; Pregnenolone; Progesterone; Prolactin; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate

1988

Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?

Menopause (New York, N.Y.), 2011, Volume: 18, Issue:1

Topics: Adult; Aged; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estradiol; Estrone; Female; Humans; Middle Aged; Ovariectomy; Ovary; Postmenopause; Statistics, Nonparametric; Testosterone

2011